A Study to Investigate the PK, Safety, and Tolerability of Sotrovimab vs Placebo Administered IV or IM in Japanese and Caucasian Participants
Clinical trial NCT04988152 · COMPLETED
Trial details
- NCT number
- NCT04988152
- Sponsor
- Vir Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-06
- Primary completion
- 2021-09-02
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.